Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by ARCH Venture Partners XII, LLC. Officer active across 4 companies, notably Neumora Therapeutics, Inc.. Cumulatively, 13 filings have been published. Split: 9 buys · 0 sell. Total volume traded: €21.7m. History available since 22 September 2023. The latest transaction was disclosed on 10 June 2024 (C). Regulator: SEC (Form 4). The full history is free.